A new study published in JAMA Internal Medicine examines the association between the initiation of cholesterol-lowering statin drug treatment and the progression of diabetes. Examining the […]
In yet another damaging development for the pharma industry’s multi-billion-dollar statins business, a large study has revealed that, in more than 51 percent of patients, the […]
A new study from Australia has linked use of cholesterol-lowering statin drugs with a significantly increased risk of idiopathic inflammatory myositis, a serious muscle disease that […]
Across the world, millions of people have high blood levels of cholesterol, triglycerides, low-density lipoproteins (LDL), lipoprotein(a), and other risk factors for cardiovascular diseases. Not yet […]
With drug industry profits from statins collapsing, a new scientific review published in the Pharmaceutical Journal – a publication of Britain’s Royal Pharmaceutical Society – […]
Cholesterol-lowering drugs form one of the largest business segments of the global pharmaceutical industry. This entire multibillion dollar business is built on fear – the fear […]
The number of people diagnosed with high cholesterol blood levels has been increasing steadily with each newly issued cholesterol guideline. Currently, about 71 million American adults […]